Drugs / APG990
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07027527 | Jun 2025 → Aug 2026 overdue | atopic eczema | Apogee Therapeutics, Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APG990 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07027527 ↗ |
| Route | Subcutaneous | “SC injection” NCT07027527 ↗ |